DRSI ReStore! Energy’s media campaign targets NYC
BOCA RATON, Fla. — Diabetica Research Solutions is spreading the word about its diabetes energy formula with a new media program that targets the New York metropolitan area.
The targeted media program for DRSI ReStore! Energy — which now is available at Duane Reade and Rite Aid pharmacies in the area — supplements the brand’s national television campaign, includes high saturation local commercial spots on television and radio, and internet banner ads to appear specifically on Web pages viewed by people in New York and the surrounding area.
"By supplementing our national television schedule with a locally targeted multimedia strategy, we can increase awareness of the brand DRSI ReStore! Energy, and expand our reach to many millions of people with diabetes," said Michael Dugan, DRSI marketing director.
DRSI ReStore! Energy is available at Kroger, Winn-Dixie, Giant Eagle, CVS.com, USA Drugs, Navarro Discount Pharmacies and more.
Millions of J&J OTC allergy and pain meds recalled
NEW BRUNSWICK, N.J. Johnson & Johnson is recalling millions of packages of over-the-counter drugs for allergies and pain due to manufacturing problems, according to published reports.
The New York Times reported Tuesday that J&J would recall 4 million packages of cherry- and grape-flavored Children’s Benadryl (diphenhydramine) tablets for allergies and 800,000 bottles of children’s Motrin (ibuprofen), a pain drug.
The company told the Times that the recall was at the wholesale and retail level and would not affect drugs already purchased by consumers.
Omron teams up with AHA to promote heart health
BANNOCKBURN, Ill. Blood pressure monitor manufacturer Omron Healthcare is working with the American Heart Association to promote heart health, Omron announced.
Under the partnership, Omron is supporting the AHA’s campaign to educate healthcare providers on treatments for high blood pressure, also known as hypertension, with the goal of reaching 50,000 providers by 2013.
“Omron Healthcare is proud to support the American Heart Association and its educational initiatives,” Omron COO Robert Kondraske said. “Hypertension affects 1-out-of-3 Americans and is known to be a silent killer.”
With November designated as American Diabetes Month, Omron also is promoting its blood pressure monitors for use by diabetics. Two-out-of-3 diabetes patients have hypertension, compared with 1-in-3 people in the general population, according to a 2004 study published in the journal Hypertension.